Cat. #154133
CHEC-9 immunomodulatory Peptide
Cat. #: 154133
Availability: Please enquire for quantities and pricing
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Timothy Cunningham
Institute: Drexel University
Tool Details
*FOR RESEARCH USE ONLY
- Tool name: CHEC-9 immunomodulatory Peptide
- Alternate name: Human neuroprotective polypeptide Diffusible Survival Evasion Peptide (DSEP)
- Sequence: CHEASAAQC
- Description: The CHEC-9 (peptide sequence CHEASAAQC) sequence is a fragment of a human diffusible survival evasion peptide (DSEP). CHEC-9 is an anti-inflammatory/neuroprotective peptide that uncompetitively binds and inhibit secreted phospholipase A2 (sPLA2). Allowing for the study of PLA2-directed inflammation of traumatic and autoimmune (Autoimmune Myeloencephalitis) neurodegenerative disorders. CHEC-9 also binds HSP70 and may influence HSP70-dependent dissolution of protein aggregates that accumulate in aging and disease models like Parkinsonâs and Alzheimerâs Disease.
Handling
- Shipping conditions: Dry Ice
References
- Cunningham et al. 2015. Rejuvenation Res. 18(2):136-44. PMID: 25485461.
- Anti-inflammatory peptide regulates the supply of heat shock protein 70 monomers: implications for aging and age-related disease.
- Secreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibition.
- Chen et al. 2012. PLoS One. 7(6):e39257. PMID: 22720084.
- Uncompetitive Phospholipase A2 Inhibition by CHEC Sequences Including Oral Treatment of Experimental Autoimmune Myeloencephalitis
- Cunningham et al. 2006. J Neuroinflammation. 3:25. PMID: 16965626.
- Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9.
- Cunningham et al. 2004. J Neurotrauma. 21(11):1683-91. PMID: 15684658.
- Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor.
